Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

October 21, 2019

Study Completion Date

May 5, 2020

Conditions
Prostate Cancer Recurrent
Interventions
OTHER

Low protein diet

Patients on this arm will receive a prescribed diet (including all food and recommendations for beverages) that contains 10% protein to begin eating 1 week prior to treatment with sipuleucel-T and throughout treatment (i.e. diet will last approximately 49 days).

OTHER

Control protein diet

Patients on this arm will receive a prescribed diet (including all food and recommendations for beverages) that contains 20% protein to begin eating 1 week prior to treatment with sipuleucel-T and throughout treatment (i.e. diet will last approximately 49 days).

Trial Locations (2)

46202

Indiana University Hospital, Indianapolis

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

All Listed Sponsors
collaborator

Indiana University School of Medicine

OTHER

lead

Indiana University

OTHER

NCT03329742 - Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer | Biotech Hunter | Biotech Hunter